This highlights the critical link between mental health and substance use, indicating that treatment must often address both conditions simultaneously for effective recovery.
Key Takeaways
- Approximately 7.4% of adult women in the United States met the criteria for a Substance Use Disorder (SUD) in the past year.7.4%[6]
- A significant treatment gap exists, with 42.4% of women who have both an SUD and a co-occurring mental illness receiving no treatment at all.42.4%[7]
- Young women aged 18-25 face the highest rates of SUD at 10.2%, a significantly higher prevalence than other female age groups.10.2%[6]
- LGBTQ+ women experience SUD at a higher rate (15.2%) compared to their heterosexual peers (9.5%), highlighting disparities in risk and access to culturally competent care.15.2%[8]
- Trauma is a major risk factor, with over 90% of women in urban, low-socioeconomic status clinic samples reporting at least one traumatic event in their lifetime.>90%[5]
- An estimated 4.2 million women in the U.S. struggle with prescription opioid abuse, a major component of the ongoing opioid crisis.4.2 million[1]
- Despite persistent barriers, the percentage of U.S. women receiving mental health treatment has steadily increased, rising from 16.9% in 2002 to 28.2% in 2024.28.2%[4]
An Overview of Substance Use Disorder in Women
Substance Use Disorder (SUD) in women involves distinct patterns of use, unique risk factors, and different consequences compared to men, necessitating a gender-informed approach to research and treatment[9]. Historically, SUD research focused predominantly on men, but there is increasing recognition of women’s specific experiences, such as higher rates of trauma exposure and unique psychosocial stressors that influence the development and progression of SUD[10]. Understanding these differences is crucial for developing effective, tailored interventions that address the specific needs of women in recovery[11].
Prevalence of Substance Use Among Women
Substance use disorders affect millions of women across the United States, with specific substances showing high rates of use and misuse. Overall, an estimated 43.4 million women aged 12 and older are affected by either a mental illness or an SUD[1]. Alcohol Use Disorder (AUD) is the most prevalent form of SUD among women, while a significant number also contend with illicit drug use and prescription opioid misuse. The data reveals a complex picture of substance use that varies by substance type and often involves polysubstance use.
This is the most common form of SUD among women in 2023.
Represents the prevalence of disorders related to substances like marijuana, cocaine, and heroin.
Highlights the challenge of polysubstance use, which can complicate treatment and recovery.
Disparities in Substance Use Disorder Among Women
Substance use disorders do not affect all women equally. Significant disparities exist across different demographic groups, with factors like age, sexual orientation, race, and socioeconomic status playing a crucial role in risk and prevalence. Younger women and those who identify as LGBTQ+ face notably higher rates of SUD. These disparities underscore the need for targeted prevention and treatment strategies that address the unique stressors and circumstances of these vulnerable populations.
The Role of Trauma and Socioeconomic Factors
Trauma and socioeconomic status are powerful determinants of mental health and substance use risk. Women, particularly those from minority and low-income backgrounds, experience disproportionately high rates of trauma, which is a significant predictor of SUD[5]. For example, women are far more likely to be exposed to childhood sexual abuse, with estimates as high as 28%[19]. Social determinants such as poverty, housing instability, and unemployment can exacerbate these risks, creating a cycle of disadvantage that is difficult to break[20].
The Treatment Gap and Barriers to Care
Despite the clear need, a vast number of women with SUD do not receive care. This treatment gap is one of the most significant challenges in public health. The delay between the onset of symptoms and the first intervention can be many years, during which time the disorder can worsen and cause significant harm to the individual, their family, and their community. Women often face gender-specific barriers to accessing treatment, including social stigma, lack of childcare, and fear of legal repercussions, which can make seeking help even more difficult[26]. In fact, women with SUD are about 1.4 times more likely to encounter systemic barriers like inadequate childcare compared to men[27].
This long delay allows the disorder to progress, leading to more severe health and social consequences.
This rate is lower than the 30% treatment rate in the overall population, indicating a gender disparity in care.
Cost and long wait times were cited as the primary obstacles preventing them from accessing care.
This comorbidity complicates diagnosis and treatment, requiring integrated care models that are not always available.
Effective Treatment Approaches for Women
Addressing substance use in women requires specialized approaches that recognize the central role of emotion regulation. Many women use substances to cope with negative emotions, and treatments that teach healthier coping strategies can be highly effective[9]. Interventions where emotion regulation skills constitute over half of the session content often yield better outcomes[33]. Therapies like Dialectical Behavior Therapy (DBT), which focus on mindfulness, distress tolerance, and emotional regulation, have shown significant success in reducing substance use among women with co-occurring disorders.
Impact of Dialectical Behavior Therapy (DBT)
Trends in Mental Health Treatment Seeking
Over the past two decades, there has been a positive trend of more women seeking and receiving mental health treatment. This increase can be attributed to several factors, including reduced stigma, expanded insurance coverage under the Affordable Care Act, and increased public awareness, particularly following the COVID-19 pandemic[4]. While this trend is encouraging, disparities in access persist, especially for women in minority groups and those in rural or underserved communities[4].
Special Population: Female Veterans
Female veterans represent a population with a unique set of risks related to their military service. They are more likely to have experienced trauma, including military sexual trauma, which significantly increases their risk for Post-Traumatic Stress Disorder (PTSD) and co-occurring SUD. The data shows a stark gender disparity in PTSD prevalence, highlighting the urgent need for gender-specific mental health services within the VA and other veteran support systems. Younger veterans are also at higher risk, with PTSD prevalence nearly three times higher in those aged 22-49 compared to older veterans (14.7% vs. 4.9%)[18].
Special Population: Female Healthcare Workers
Female healthcare workers face immense pressure, high-stress environments, and burnout, which can contribute to the development of substance use disorders. The prevalence of SUD has been increasing in this population, yet many are reluctant to seek help due to stigma and fear of professional repercussions, such as losing their license[36]. This creates a silent crisis where those who care for others struggle to find care for themselves, impacting both their well-being and potentially patient safety[37].
Special Population: Maternal Mental Health
The perinatal period is a time of significant vulnerability for mental health conditions, including postpartum depression (PPD) and anxiety (PPA). These conditions are common, yet they often go undiagnosed and untreated, with fewer than 20% of new mothers being routinely screened[2]. Untreated maternal mental health disorders can have serious consequences for both the mother and child, and may increase the risk of substance use as a coping mechanism. Rates are particularly high among low-income individuals, adolescents, and certain racial and ethnic groups[41].
Affects nearly one in seven mothers, with some states reporting rates as high as one in five.
Often co-occurs with PPD but is a distinct condition that also requires clinical attention.
Frequently Asked Questions
Sources & References
All statistics and claims on this page are supported by peer-reviewed research and official government data sources.